Angiogenesis

Fetal and Neonatal Physiology: Third Edition

Volumn 1-2, Issue , 2003, Pages 79-84

  Aron, Elisabeth A ^a,b   Anthony, Russell V ^a,c  

^a Department of Ecosystem Science and Sustainability   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Nutrition Obesity Research Center at the University of Colorado   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84911080672     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9654-6.50012-6     Document Type: Chapter

References (86)

1. Pardanaud L, et al. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 1989, 105:473.
2. Fox SB Tumor angiogenesis and prognosis. Histopathology 1997, 30:294.
3. Polverini PJ Cellular adhesion molecules: newly identified mediators of angiogenesis. Am J Pathol 1996, 148:1023.
4. Folkman J How is blood vessel growth regulated in normal and neoplastic tissue?. Cancer Res 1986, 46:467.
5. Folkman J What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 1990, 82:4.
6. Conway EM, et al. Molecular mechanisms of blood vessel growth. Cardiovasc Res 2001, 49:507.
7. Risau W, Flamme I Vasculogenesis. Annu Rev Cell Dev Biol 1995, 11:73.
8. Risau W Mechanisms of angiogenesis. Nature 1997, 386:671.
9. Flamme I, et al. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 1997, 173:206.
10. Polverni PJ The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 1995, 6:230.
11. Gonzalez Crussi F Vasculogenesis in the chick embryo: an ultrastructural study. Am J Anat 1971, 130:441.
12. Huang R, et al. The fate of somitocoele cells in avian embryos. Anat Embryol 1994, 190:243.
13. Wilting J, et al. Angiogenic potential of the avian somite. Dev Dyn 1995, 202:165.
14. Klessinger S, Christ B Axial structures control laterality in the distribution pattern of endothelial cells. Anat Embryol 1996, 193:319.
15. Huang R, et al. The fate of the first avian somite. Anat Embryol 1997, 195:435.
16. Pardanaud L, et al. Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. Development 1987, 100:339.
17. Dieterlen LF, et al. Early haemopoietic stem cells in the avian embryo. J Cell Sci 1988, 10(Suppl):29.
18. Wagner RC Endothelial cell embryology and growth. Adv Microcirc 1980, 9:47.
19. Noden DM Development of craniofacial blood vessels. The Development of the Vascular System 1991, 1-24. S. Karger, Basel. R.N. Feinberg (Ed.).
20. Tomanek RJ, et al. Rate of coronary vascularization during embryonic chicken development is influenced by the rate of myocardial growth. Cardiovasc Res 1999, 41:663.
21. Demir R, et al. Fetal vasculogenesis and angiogenesis in human placental villi. Acta Anat 1989, 136:190.
22. Ahmed A, Perkins J Angiogenesis and intrauterine growth restriction. Baillieres Clin Obstet Gynecol 2000, 14:981.
23. Kohnen G, et al. Placental villous stroma as a model system for myofibroblast differentiation. Histochem Cell Biol 1996, 105:415.
24. Kingdom J, et al. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol 2000, 92:35.
25. Neufield G, et al. Vascular endothelial growth factor and its receptors. Prog Growth Factor Res 1994, 5:89.
26. Ferrara N, et al. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991, 47:211.
27. Olofsson B, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996, 93:2576.
28. Joukov V, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996, 15:290.
29. Achen MG, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998, 95:548.
30. Ogawa S, et al. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J Biol Chem 1998, 273:31273.
31. Firbrother WJ, et al. Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure 1998, 6:637.
32. Torry DS, Torry RJ Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am J Reprod Immunol 1997, 37:21.
33. Charnock-Jones DS, et al. Identification and localization of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial cell lines. Biol Reprod 1993, 48:1120.
34. Cao Y, et al. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun 1997, 235:493.
35. Thomas KA Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 1996, 271:603.
36. Veikkola T, Alitalo K VEGFs, receptors and angiogenesis. Semin Cancer Biol 1999, 9:211.
37. Clark DK, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998, 59:1540.
38. He Z, Tessier-Lavigne M Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 1997, 90:739.
39. Gluzman-Poltorak Z, et al. Neuropilin-2 and neuropilin-1 are receptors for the 165-amino acid form of vascular endothelial growth factor (VEGF) and of placenta growth factor-2, but only neuropilin-2 functions as a receptor for the 145-amino acid form of VEGF. J Biol Chem 2000, 275:18040.
40. Makinen T, et al. Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J Biol Chem 1999, 274:21217.
41. Wise LM, et al. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl Acad Sci USA 1999, 96:3071.
42. Migdal M, et al. Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem 1998, 273:22272.
43. Fuh G, et al. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor Flt-1. J Biol Chem 2000, 275:26690.
44. Shore VH, et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997, 18:657.
45. Tudor RM, et al. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia: modulation of gene expression by nitric oxide. J Clin Invest 1995, 95:1798.
46. Shih SC, Claffey KP Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogenous nuclear ribonucleoprotein L. J Biol Chem 1999, 274:1359.
47. 2 tension. Proc Natl Acad Sci USA 1995, 92:5510.
48. 2 sensing. Science 2001, 292:464.
49. Maxwell PH, et al. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399:271.
50. Maxwell PH, Ratcliffe PJ Oxygen sensors and angiogenesis. Semin Cell Dev Biol 2002, 13:29.
51. Gnarra JR, et al. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci USA 1997, 94:9102.
52. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev 1998, 12:149.
53. Maltepe E, et al. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997, 386:403.
54. Peng J, et al. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling. Proc Natl Acad Sci USA 2000, 97:8386.
55. Tian H, et al. The hypoxia responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 1998, 12:3320.
56. Oh H, et al. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999, 274:15732.
57. Koblizek TI, et al. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 1998, 8:529.
58. Maisonpierre PC, et al. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science 1997, 277:50.
59. Yancopoulos GD, et al. Vasculogenesis, angiogenesis and growth factors: ephrins enter the fray at the border. Cell 1998, 93:661.
60. Ashara T, et al. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998, 83:233.
61. Suri C, et al. Required role of angiopoietin-1, a ligand for the Tie 2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171.
62. Sato TN, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70.
63. Thurston G, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999, 286:2511.
64. Ferrara N, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996, 380:439.
65. Carmeliet P, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435.
66. Shalaby F, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995, 376:62.
67. Fong GH, et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995, 376:66.
68. Carmeliet P, Collen D Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Topics Microbiol Immunol 1997, 237:133.
69. Vuorela P, et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997, 56:489.
70. Charnock-Jones DS, et al. Localization and activation of the receptor for vascular endothelial growth factor on human trophoblast and choriocarcinoma cells. Biol Reprod 1994, 51:524.
71. Vuckovic M, et al. Expression of vascular endothelial growth factor receptor, KDR, in human placenta. J Anat 1996, 188:361.
72. Ahmed AS, et al. Colocalisation of vascular endothelial growth factor and its flt-1 receptor in human placenta. Growth Factors 1995, 12:235.
73. Kingdom JC, Kaufmann P Oxygen and placental vascular development. Adv Exp Med Biol 1999, 474:259.
74. Schweiki D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia initiated angiogenesis. Nature 1992, 359:843.
75. Meekins JW, et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994, 101:669.
76. Redline RW, Patterson P Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol 1995, 26:594.
77. Roberson WB, et al. Uteroplacenta vascular pathology. Eur J Obstet Gynecol Reprod Biol 1975, 5:47.
78. Kingdom JC, Kaufmann P Oxygen and placental villous development: origins of fetal hypoxia. Placenta 1997, 18:613.
79. Cooper JC, et al. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol 1996, 103:1191.
80. Lyall F, et al. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997, 18:269.
81. Torry DS, et al. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998, 179:1539.
82. Tidwell SC, et al. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001, 184:1267.
83. Pardi G, et al. Venous drainage of the human uterus: respiratory gas studies in normal and fetal growth-retarded pregnancies. Am J Obstet Gynecol 1992, 166:699.
84. Khaliq A, et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest 1999, 79:151.
85. Dunk C, et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development. Am J Pathol 2000, 156:2185.
86. Goldman-Wohl DS, et al. Tie-2 and angiopoietin-2 expression at the fetal-maternal interface: a receptor ligand model for vascular remodeling. Mol Hum Reprod 2000, 6:81.